$RNN Headlines Rexahn prices offering at 30% discount

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$RNN Headlines

Rexahn prices offering at 30% discount 10:58 a.m. Nov. 29, 2012 - MarketWatch.com
AEterna falls; Inspire, Rexahn rally 2:15 p.m. April 16, 2010 - Val Brickates Kennedy
Javelin rockets, Myriad gains on scrapped merger 12:20 p.m. April 12, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 3:26 p.m. April 7, 2010 - MarketWatch
Rexahn, Avanir gain; Sequenom falls 12:32 p.m. April 7, 2010 - Val Brickates Kennedy
Letter up 230% last year without trading 3:00 a.m. Jan. 11, 2010 - Peter Brimelow

Morning Market Losers 9:02 a.m. Today - benzinga.com
Morning Market Movers 8:55 a.m. Jan. 13, 2014 - benzinga.com
Why Rexahn Pharmaceuticals (RNN) Is Up Today 10:35 a.m. Jan. 10, 2014 - TheStreet.com
Rexahn up 15% after Buy rating 1:25 p.m. Jan. 9, 2014 - Seeking Alpha
Rexahn's Replacement For Eli Lilly's Gemzar Enters New Clinical Trial 12:20 p.m. Jan. 9, 2014 - Seeking Alpha
Rexahn: A Turn Around Story For 2014 12:49 p.m. Dec. 22, 2013 - Seeking Alpha
Rexahn's Akt-1 Inhibitor To Begin Phase II Trials For Kidney Treatment 1:47 p.m. Nov. 25, 2013 - Seeking Alpha
Rexahn's Recent Clinical Data Points To A New And Better Chemotherapy Pill 7:57 p.m. Oct. 6, 2013 - Seeking Alpha
Rexahn Pharmaceuticals Announces Publication of Preclinical Data for Novel Anti-Cancer Compound RX-3117 6:02 a.m. Sept. 30, 2013 - benzinga.com
Rexahn Regains Rights To Novel Cancer Drug As Teva Continues Its Pipeline Stumble 4:06 p.m. Sept. 5, 2013 - Seeking Alpha
Teva-Rexahn Deal Terminated - Analyst Blog 10:40 a.m. Aug. 30, 2013 - Zacks.com
10-Q: REXAHN PHARMACEUTICALS, INC. 3:15 p.m. Aug. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
Rexahn Pharmaceuticals Initiates Dosing in Phase I Trial of SupinoxinTM (RX-5902) a Candidate for Treating Solid Cancer Tumors 6:01 a.m. Aug. 7, 2013 - benzinga.com
Rexahn's CEO Uses A Business-Driven Cancer Model For Shareholder Value 5:34 p.m. Aug. 5, 2013 - Seeking Alpha
Rexahn Redesigns Cancer Superdrug Taxotere 12:58 p.m. July 18, 2013 - Seeking Alpha
Rexahn Pharmaceuticals In-Licenses Breakthrough Oncology Drug Delivery Platform 6:05 a.m. July 17, 2013 - benzinga.com
Rexahn Pharmaceuticals Announce IND Submission for RX-3117 6:05 a.m. July 15, 2013 - benzinga.com
Rexahn Pharma Wins US Patent for Novel Anti-Cancer Compounds 6:06 a.m. June 17, 2013 - benzinga.com
Rexahn's Oncology Platform Led By Its Akt-1 Inhibitor Challenges Big Pharma With Ground-Breaking Cancer Therapy 4:53 a.m. June 5, 2013 - Seeking Alpha
10-Q: REXAHN PHARMACEUTICALS, INC. 3:15 p.m. May 9, 2013 - Edgar Online - (EDG = 10Q, 10K)


Rexahn Initiates Phase IIa Clinical Trial of Archexin® in Patients with Metastatic Renal Cell Carcinoma 9:00 a.m. Today - BusinessWire - BZX
Rexahn Initiates Phase Ib Clinical Trial of RX-3117 for Treatment of Solid Tumors 8:00 a.m. Jan. 8, 2014 - BusinessWire
Rexahn Pharmaceuticals to Present at the Biotech Showcase 2014 8:00 a.m. Jan. 7, 2014 - BusinessWire
Rexahn Receives Method Patent for Treatment of Solid Tumor Cancers for Supinoxin (TM) (RX-5902) 8:17 a.m. Dec. 11, 2013 - BusinessWire
Rexahn Pharmaceuticals to Participate in Brean Capital 2013 Life Sciences Summit 8:00 a.m. Nov. 19, 2013 - BusinessWire
Rexahn Pharmaceuticals Reports Third Quarter Financial Results and Pipeline Update 8:00 a.m. Nov. 14, 2013 - BusinessWire
Rexahn Announces $5.3 Million At Market Registered Direct Offering 8:00 a.m. Oct. 11, 2013 - BusinessWire
Rexahn Pharmaceuticals In-Licenses Novel Oligonucleotide Targeted Drug Delivery Platform from Ohio State University 7:00 a.m. Oct. 10, 2013 - BusinessWire
Rexahn Pharmaceuticals Announces Publication of Preclinical Data for Novel Anti-Cancer Compound RX-3117 7:00 a.m. Sept. 30, 2013 - BusinessWire
Rexahn Awarded Patent in Europe for Cancer Drug Archexin(R) 7:00 a.m. Sept. 12, 2013 - BusinessWire
Rexahn Pharmaceuticals to Present at the 15th Annual Rodman & Renshaw Global Investment Conference on September 9, 2013 7:00 a.m. Sept. 5, 2013 - BusinessWire
Rexahn Pharmaceuticals Provides a Clinical Development and Financial Update 7:00 a.m. Sept. 4, 2013 - BusinessWire
Rexahn Pharmaceuticals Announces Teva will not Exercise its Option to License RX-3117 8:00 a.m. Aug. 28, 2013 - BusinessWire
Rexahn Pharmaceuticals Initiates Dosing in Phase I Trial of Supinoxin(TM) (RX-5902) a Candidate for Treating Solid Cancer Tumors 7:00 a.m. Aug. 7, 2013 - BusinessWire
University Of Maryland, Baltimore's Licensing Deals Fuel Local Life Sciences Community 7:30 a.m. Aug. 6, 2013 - PR Newswire
Rexahn Pharmaceuticals Announces $5.7 Million Registered Direct Offering 8:00 a.m. July 24, 2013 - BusinessWire
Rexahn Pharmaceuticals In-Licenses Breakthrough Oncology Drug Delivery Platform 7:00 a.m. July 17, 2013 - BusinessWire
Rexahn Pharmaceuticals Announce IND Submission for RX-3117 7:00 a.m. July 15, 2013 - BusinessWire
Rexahn Pharmaceuticals Awarded Patent in Japan for Novel Anti-cancer Isoquinolinamine Compounds 7:00 a.m. July 9, 2013 - BusinessWire
Rexahn Awarded U.S. Patent for Novel Anti-Cancer Compounds 7:00 a.m. June 17, 2013 - BusinessWire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 0

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading
Goodwill's ReThink Fashion: Textiles to Runway Art

Updated Category News Views 3

Transforming Old to New on the Runway Right when you think fashion's all about the next shiny thing, here comes Goodwill of Delaware & Delaware County flipping the script. Their ReThink Fashion Show - the ECO Edit teaches us a thing or two about what giving old clothes a new life truly means. It's not just about tossing a used tee onto a catwalk but a whole rebirth...

Continue Reading
Give Lively & Change Simplify CA Nonprofit Compliance

Updated Category News Views 0

A Fresh Wind Blowing for California Nonprofits So, here's a twist in the nonprofit world that's stirring the pot just right. Give Lively and Change have partnered up to tackle the thorny issue of regulatory compliance in California. It's a big win for the nonprofits looking to keep fundraising through Give Lively without getting tangled in the bureaucratic web spun up by...

Continue Reading
LeoLabs and SciTec Partner for $93.7M Space Force Deal

Updated Category News Views 0

LeoLabs and SciTec Join Forces for Space Dominance The space race ain't just about rockets blasting off anymore. It's about making sure we've got eyes everywhere, even on the back of our heads, so to speak. Enter LeoLabs teaming up with SciTec to help the U.S. Space Force upgrade their radar systems to something out of a sci-fi flick, armed with a $93.7 million contract...

Continue Reading
Webinar Highlights Workforce Skills and AI Tools

Updated Category News Views 3

The Shift Towards Skills-Based Talent Development The labor market's in a whirl, folks. Employers are scrambling to adapt to rapid changes, chasing after 'skills intelligence' like it's going out of style. On September 24, University of Phoenix, with its band of partners including Jobs for the Future and Skillmore™, will dig into this very topic. This upcoming webinar...

Continue Reading
RevSystems Joins Elite OpenAI Partner Network

Updated Category News Views 0

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Continue Reading
Spot the Signs: Early Gum Disease Insights from Experts

Updated Category News Views 2

Why Early Detection of Gum Disease Matters Let's dive right into the crux of things. Gum disease, that sneaky antagonist of oral health, starts unassumingly. You brush, you floss, but those gums might still bleed—ever noticed? Dr. Marian Burgard of Fairport Family Dental has a thing or two to say about this, enlightening us through an insightful piece by HelloNation....

Continue Reading
Alif Semiconductor Unveils StartKit for Edge AI MCU Fam

Updated Category News Views 3

Here's some clarity amidst the storm of buzzwords: Alif Semiconductor has rolled out something the market's been howling for—Edge AI that doesn't break the bank. It's less about slick press releases and more about real-world implications. We're talking accessibility with their dirt-cheap, small-form-factor StartKit platform for Ensemble and Balletto microcontrollers....

Continue Reading
Wave Kids™ Unveils New Flavors for Kids' Drinks

Updated Category News Views 0

Sparking a Fresh Wave in the Kids' Beverage Market Alright, let me tell you about a new player plowing into the kids' drink scene. Wave Kids™, a brand that's making waves—pun intended—has a fresh lineup that screams 'fun' and 'healthy' in equal measure. Just coinciding with back-to-school season, this Scottsdale, Arizona outfit has rolled out not one or two, but...

Continue Reading
Job Market Shifts: Adaptation vs. Fairness Dilemma

Updated Category News Views 1

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Continue Reading

Top 5 Most Recently Viewed Articles

Advanced Micro Devices Announces Stellar Q3 2025 Results

Updated Category News Views 216

Overview of AMD's Financial Achievements in Q3 2025 AMD has once again showcased remarkable growth in its financials with its third quarter results highlighting an outstanding $9.2 billion in revenue. This reflects a robust 36% increase year-over-year, underscoring the company’s strategic initiatives focused on high-performance computing and AI technology. Revenue and...

Continue Reading
Bety.com Revolutionizes Online Casino Experience with Web3

Updated Category News Views 248

Bety.com Revolutionizing Online Casino Gaming Bety.com, the forefront player in the decentralized casino landscape, is making waves within the Web3 space. As the first decentralized crypto casino, it blends advanced blockchain technology with an enhanced user experience, setting benchmarks that traditional casinos struggle to meet. The platform’s groundbreaking...

Continue Reading
Join the $CREATE Fund Challenge: Win Tokens with Own. App!

Updated Category News Views 145

Own. App and $CREATE Fund Launch Token Challenge In a remarkable effort to transform creator interactions on social media, Own. App has teamed up with the $CREATE Fund to unveil a new and exciting initiative. This unique challenge, dubbed the Own. App x $CREATE Fund Token Challenge, aims to empower users and creators alike. Opportunity to Win 100 Million Tokens...

Continue Reading
Dollar General Shares Rise as Analysts Adjust Financial Outlook

Updated Category News Views 152

Dollar General Reports Impressive Q2 Earnings Performance Dollar General Corporation (NYSE: DG) has recently announced a strong performance in its second-quarter earnings, surpassing expectations and prompting a positive shift in financial forecasts. The company's net sales reached an impressive $10.72 billion, marking a 5.1% increase compared to the previous year. This...

Continue Reading
BRT Apartments Corp. Reports Annual Financial Results for 2024

Updated Category News Views 146

BRT Apartments Corp. Unveils 2024 Financial Report GREAT NECK, N.Y. — BRT APARTMENTS CORP. (NYSE: BRT) has recently announced its filing of the annual report on Form 10-K with the Securities and Exchange Commission for the fiscal year ending December 31, 2024. This comprehensive report includes the financial statements, highlighting the company's performance and future...

Continue Reading